<DOC>
	<DOCNO>NCT00266240</DOCNO>
	<brief_summary>This study evaluate efficacy , safety , tolerability , pharmacokinetics oral GK Activator ( 2 ) , compare placebo , patient type 2 diabetes mellitus . The anticipated time study treatment le 3 month , target sample size 100-500 individual .</brief_summary>
	<brief_title>A Study GK Activator ( 2 ) Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>adult patient 3075 year age ; type 2 diabetes mellitus &gt; 3 month screen ; treatmentnaive , inadequately control diabetes despite diet exercise , inadequately control diabetes patient monotherapy combination therapy ( maximum 2 oral antihyperglycemic medication ) . type 1 diabetes mellitus ; woman pregnant , breastfeed use adequate contraceptive method .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>